Analysis of portal vein thrombosis of portal hypertension after pericardial devascularization by prophylactic anticoagulation
10.3760/cma.j.issn.1008-6315.2015.11.019
- VernacularTitle:门静脉高压症贲门周围血管离断术后预防性抗凝对门静脉系统血栓形成的影响
- Author:
Zhikun LU
;
Yongqiang WU
;
Jinhua YANG
;
Demou HE
;
Quanfeng ZHANG
- Publication Type:Journal Article
- Keywords:
Portal hypertension;
Portal vein thrombosis;
low molecular dextran;
Aspirin;
Complications
- From:
Clinical Medicine of China
2015;31(11):1020-1023
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of pathogenesis,diagnosis,therapy and prevention of portal vein thrombosis(PVT) after devascularization.Methods Data of 86 patients who underwent devascularization because of cirrhotic portal hypertension between January 2009 and December 2014 were retrospectively analyzed.Patients were divided into preventive anticoagulant treatment group (46 cases) and nonpreventive anticoagulant treatment group (40 cases) according to whether or not to receive prophylactic anticoagulant therapy.Compared the causes of PVT and clinical characters.Results The occurrence of PVT was 10.9％ (5/ 46) in preventive anticoagulant treatment group,PVT Ⅰ , Ⅱ, Ⅲ, Ⅳdegree were 2,3,0,0 cases,and that was 32.5％ (13/40) in nonpreventive anticoagulant treatment group, PVT Ⅰ , Ⅱ , Ⅲ, Ⅳ degree were 4,7,2,0 cases, the incidence rate of treatment group was lower than control group (x2 =9.735, P ＜ 0.05).There was no relationship in PVT with sex, age, and intraoperative ligation of splenic artery beforehand (P＞0.05).There were apparent correlation in PVT with centrifugal-flow of portal vein and peak value of platelet count(P＜0.05).All patients discharged uneventfully after anticoagulant treatment, including 2 cases of thrombolytic and 4 cases of blood supply recanalization, no case died from PVT.Conclusion The definite cause of PVT after devascularization is centrifugal-flow of portal vein and the peak value of platelet count (300-499) × 109/L is a pivotal risk factor.The key point of therapy is early diagnosis and early anticoagulant treatment.
